Hydrogel delivery of sting immunotherapy for treatment cancer
US11969499B2 · kind B2 · utility
0Cited by
6References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 15, 2018 |
| Grant date | Apr 30, 2024 |
| Priority date | — |
| Expiry date | Aug 9, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the present disclosure provides for novel compositions of matter comprising multi domain peptide (MDP) hydrogels and cyclic dinucleotides (CDNs). Also disclosed are method of using such compositions in the treatment of cancer, including in particular the treatment of head and neck cancers, such as those resistant to CDN therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.